메뉴 건너뛰기




Volumn 104, Issue 1, 2003, Pages 98-103

Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene

Author keywords

Loss of heterozygosity; Stage; Stage progression; Superficial bladder cancer; Survival

Indexed keywords

CYTOSINE; GENE PRODUCT; GUANINE; PROTEIN CDKN2A; THYMINE; UNCLASSIFIED DRUG;

EID: 0037430195     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10919     Document Type: Article
Times cited : (33)

References (44)
  • 1
    • 0027769876 scopus 로고
    • A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
    • Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366:704-7.
    • (1993) Nature , vol.366 , pp. 704-707
    • Serrano, M.1    Hannon, G.J.2    Beach, D.3
  • 3
    • 0029587551 scopus 로고
    • Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
    • Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
    • (1995) Cell , vol.83 , pp. 993-1000
    • Quelle, D.E.1    Zindy, F.2    Ashmun, R.A.3    Sherr, C.J.4
  • 7
    • 0031717333 scopus 로고    scopus 로고
    • Molecular alterations in bladder cancer
    • Orntoft TF, Wolf H. Molecular alterations in bladder cancer. Urol Res 1998;26:223-33.
    • (1998) Urol Res , vol.26 , pp. 223-233
    • Orntoft, T.F.1    Wolf, H.2
  • 8
    • 0032484559 scopus 로고    scopus 로고
    • Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder
    • Van Tilborg AA, Hekman AC, Vissers KJ, van der Kwast TH, Zwarthoff EC. Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. Int J Cancer 1998;75:9-14.
    • (1998) Int J Cancer , vol.75 , pp. 9-14
    • Van Tilborg, A.A.1    Hekman, A.C.2    Vissers, K.J.3    Van der Kwast, T.H.4    Zwarthoff, E.C.5
  • 10
    • 0343923480 scopus 로고    scopus 로고
    • Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS 1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization
    • Balazs M, Carroll P, Kerschmann R, Sauter G, Waldman FM. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS 1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 1997;19:84-9.
    • (1997) Genes Chromosomes Cancer , vol.19 , pp. 84-89
    • Balazs, M.1    Carroll, P.2    Kerschmann, R.3    Sauter, G.4    Waldman, F.M.5
  • 12
    • 0028875205 scopus 로고
    • Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
    • Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55: 4531-5.
    • (1995) Cancer Res , vol.55 , pp. 4531-4535
    • Gonzalez-Zulueta, M.1    Bender, C.M.2    Yang, A.S.3    Nguyen, T.4    Beart, R.W.5    Van Tornout, J.M.6    Jones, P.A.7
  • 17
    • 0028789685 scopus 로고
    • Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers
    • Miyamoto H, Kubota Y, Fujinami K, Dobashi Y, Kondo K, Yao M, Shuin T, Hosaka M. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers. Oncol Res 1995;7:327-30.
    • (1995) Oncol Res , vol.7 , pp. 327-330
    • Miyamoto, H.1    Kubota, Y.2    Fujinami, K.3    Dobashi, Y.4    Kondo, K.5    Yao, M.6    Shuin, T.7    Hosaka, M.8
  • 18
    • 0028879681 scopus 로고
    • Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors
    • Packenham JP, Taylor JA, Anna CH, White CM, Devereux TR. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Mol Carcinog 1995;14:147-51.
    • (1995) Mol Carcinog , vol.14 , pp. 147-151
    • Packenham, J.P.1    Taylor, J.A.2    Anna, C.H.3    White, C.M.4    Devereux, T.R.5
  • 19
    • 0031067521 scopus 로고    scopus 로고
    • Decreased expression of the p16/MTS1 gene without mutation is frequent in human urinary bladder carcinomas
    • Asamoto M, Iwahori Y, Okamura T, Shirai T, Tsuda H. Decreased expression of the p16/MTS1 gene without mutation is frequent in human urinary bladder carcinomas. Jpn J Clin Oncol 1997;27:22-5.
    • (1997) Jpn J Clin Oncol , vol.27 , pp. 22-25
    • Asamoto, M.1    Iwahori, Y.2    Okamura, T.3    Shirai, T.4    Tsuda, H.5
  • 20
    • 0033087687 scopus 로고    scopus 로고
    • p16 involvement in primary bladder tumors: Analysis of deletions and mutations
    • Baud E, Catilina P, Bignon YJ. p16 involvement in primary bladder tumors: analysis of deletions and mutations. Int J Oncol 1999;14: 441-5.
    • (1999) Int J Oncol , vol.14 , pp. 441-445
    • Baud, E.1    Catilina, P.2    Bignon, Y.J.3
  • 22
    • 0032517341 scopus 로고    scopus 로고
    • The p161NK4a/CDKN2A tumor suppressor and its relatives
    • Ruas M, Peters G. The p161NK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998;1378:F115-77.
    • (1998) Biochim Biophys Acta , vol.1378
    • Ruas, M.1    Peters, G.2
  • 23
    • 0032545582 scopus 로고    scopus 로고
    • Mutations in the CDKN2A (p161NK4a) gene in microdissected sporadic primary melanomas
    • Kumar R, Lundh Rozell B, Louhelainen J, Hemminki K. Mutations in the CDKN2A (p161NK4a) gene in microdissected sporadic primary melanomas. Int J Cancer 1998;75:193-8.
    • (1998) Int J Cancer , vol.75 , pp. 193-198
    • Kumar, R.1    Lundh Rozell, B.2    Louhelainen, J.3    Hemminki, K.4
  • 24
    • 0035923248 scopus 로고    scopus 로고
    • A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare
    • Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA, Hemminki K. A single nucleotide polymorphism in the 3′ untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 2001;95:388-93.
    • (2001) Int J Cancer , vol.95 , pp. 388-393
    • Kumar, R.1    Smeds, J.2    Berggren, P.3    Straume, O.4    Rozell, B.L.5    Akslen, L.A.6    Hemminki, K.7
  • 26
    • 0036313607 scopus 로고    scopus 로고
    • Significant impact of promoter hypermethylation and the C→T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase
    • Straume O, Smeds J, Kumar R, Hemmiki K, Akslen LA. Significant impact of promoter hypermethylation and the C→T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol 2002;161:229-37.
    • (2002) Am J Pathol , vol.161 , pp. 229-237
    • Straume, O.1    Smeds, J.2    Kumar, R.3    Hemmiki, K.4    Akslen, L.A.5
  • 32
    • 0025185642 scopus 로고
    • Staging of bladder cancer: Is the tumor, node, metastasis system adequate?
    • Hall RR, Prout GR. Staging of bladder cancer: is the tumor, node, metastasis system adequate? Semin Oncol 1990;17:517-23.
    • (1990) Semin Oncol , vol.17 , pp. 517-523
    • Hall, R.R.1    Prout, G.R.2
  • 33
    • 0013808343 scopus 로고
    • Classification of bladder tumors based on the cellular pattern. Preliminary report of a clinicalpathological study of 300 cases with a minimum follow-up of eight years
    • Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumors based on the cellular pattern. Preliminary report of a clinicalpathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965;130:371-8.
    • (1965) Acta Chir Scand , vol.130 , pp. 371-378
    • Bergkvist, A.1    Ljungqvist, A.2    Moberger, G.3
  • 34
    • 0032794625 scopus 로고    scopus 로고
    • Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): Homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas
    • Kumar R, Smeds J, Lundh Rozell B, Hemminki K. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas. Melanoma Res 1999;9:138-47.
    • (1999) Melanoma Res , vol.9 , pp. 138-147
    • Kumar, R.1    Smeds, J.2    Lundh Rozell, B.3    Hemminki, K.4
  • 35
    • 0034672289 scopus 로고    scopus 로고
    • Single nucleotide polymorphism analyses of the human proliferating cell nuclear antigen (pCNA) and flap endonuclease (FEN1) genes
    • Ma X, Jin Q, Forsti A, Hemminki K, Kumar R. Single nucleotide polymorphism analyses of the human proliferating cell nuclear antigen (pCNA) and flap endonuclease (FEN1) genes. Int J Cancer 2000;88:938-42.
    • (2000) Int J Cancer , vol.88 , pp. 938-942
    • Ma, X.1    Jin, Q.2    Forsti, A.3    Hemminki, K.4    Kumar, R.5
  • 38
    • 0035079268 scopus 로고    scopus 로고
    • Molecular and kinetic features of transitional cell carcinomas of the bladder: Biological and clinical implications
    • Baithun SI, Naase M, Blanes A, Diaz-Cano SJ. Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications. Virchows Arch 2001;438:289-97.
    • (2001) Virchows Arch , vol.438 , pp. 289-297
    • Baithun, S.I.1    Naase, M.2    Blanes, A.3    Diaz-Cano, S.J.4
  • 39
    • 0029042453 scopus 로고
    • The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years
    • discussion 1826-7
    • Holmang S, Hedelin H, Anderstrom C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823-6; discussion 1826-7.
    • (1995) J Urol , vol.153 , pp. 1823-1826
    • Holmang, S.1    Hedelin, H.2    Anderstrom, C.3    Johansson, S.L.4
  • 40
    • 0034101197 scopus 로고    scopus 로고
    • The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology?
    • Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 2000;6:637-41.
    • (2000) Nat Med , vol.6 , pp. 637-641
    • Conne, B.1    Stutz, A.2    Vassalli, J.D.3
  • 42
    • 0033787302 scopus 로고    scopus 로고
    • DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder
    • Florl AR, Franke KH, Niederacher D, Gerharz CD, Seifert HH, Schulz WA. DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder [In Process Citation]. Lab Invest 2000;80:1513-22.
    • (2000) Lab Invest , vol.80 , pp. 1513-1522
    • Florl, A.R.1    Franke, K.H.2    Niederacher, D.3    Gerharz, C.D.4    Seifert, H.H.5    Schulz, W.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.